Wealthspan Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $644K | Sell |
3,471
-123
| -3% | -$22.8K | 0.27% | 55 |
|
2025
Q1 | $753K | Sell |
3,594
-258
| -7% | -$54.1K | 0.35% | 49 |
|
2024
Q4 | $685K | Buy |
3,852
+39
| +1% | +$6.93K | 0.33% | 53 |
|
2024
Q3 | $753K | Hold |
3,813
| – | – | 0.37% | 51 |
|
2024
Q2 | $654K | Hold |
3,813
| – | – | 0.36% | 49 |
|
2024
Q1 | $694K | Buy |
3,813
+144
| +4% | +$26.2K | 0.41% | 44 |
|
2023
Q4 | $569K | Buy |
3,669
+271
| +8% | +$42K | 0.4% | 42 |
|
2023
Q3 | $507K | Buy |
3,398
+1
| +0% | +$149 | 0.4% | 45 |
|
2023
Q2 | $458K | Buy |
3,397
+6
| +0.2% | +$808 | 0.36% | 42 |
|
2023
Q1 | $540K | Sell |
3,391
-5
| -0.1% | -$797 | 0.46% | 41 |
|
2022
Q4 | $549K | Buy |
3,396
+124
| +4% | +$20K | 0.5% | 38 |
|
2022
Q3 | $439K | Buy |
3,272
+30
| +0.9% | +$4.03K | 0.45% | 40 |
|
2022
Q2 | $497K | Buy |
3,242
+189
| +6% | +$29K | 0.51% | 36 |
|
2022
Q1 | $495K | Buy |
3,053
+8
| +0.3% | +$1.3K | 0.45% | 40 |
|
2021
Q4 | $412K | Buy |
+3,045
| New | +$412K | 0.36% | 46 |
|